Reports Q4 revenue $1.7B vs. $1.6B last year. “ICL (ICL) delivered a solid finish to 2025, with fourth quarter sales increasing 6% to $1.7 billion and adjusted EBITDA improving 10% to $380 million. All four of our segments delivered sales growth, with sales for our Industrial Products, Phosphate Solutions and Growing Solutions segments up 4% in the fourth quarter, and we remain committed to growing our leadership position in these segments,” said Elad Aharonson, president and CEO of ICL. “Throughout 2025, we benefitted from our distinctive global presence and relied on our regionally diversified operations to expand our specialties solutions offerings to our global customers using local production. This focus helped us to deliver a 5% increase in sales in 2025.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICL:
- ICL Upcoming Earnings Report: What to Expect?
- ICL Group Seals Binding Agreement With Israel on $2.54 Billion Dead Sea Concession Asset Transfer
- ICL price target raised to $6.15 from $5.80 at Morgan Stanley
- ICL Signs 2026 Potash Supply Contracts With Chinese Customers
- ICL Group Files December 2025 Investor Presentation Highlighting Growth in Crop Nutrition and Functional Ingredients
